RxDoctor Payments Data

Thomas Kang, MD

Otology & Neurotology · Oro Valley, AZNPI 1588766604

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.

$6,440in general payments, 2019–2025

Across 179 payments — averaging $35.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Acclarent, Inc$746
  • Aerin Medical Inc.$591
  • Sanofi$556
  • GSK$539
  • Medtronic$481
  • plus $2K from 18 others

What the payments were for

  • Travel & lodging$1212%
  • Food & beverage$6,31898%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$507,526
Medicare patients
1,421
Services billed
4,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$45,617
Ipratropium Bromide795$22,554
Azelastine Hcl344$13,665
Montelukast Sodium292$2,812
Fluocinolone Acetonide Oil66$2,681
Fluticasone Propionate109$2,044
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,463
Mometasone Furoate23$1,198
Methylprednisolone62$502
Triamcinolone Acetonide13$460
Gabapentin65$412
Ofloxacin15$406
Prednisone91$387
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$362
Dexamethasone17$293

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Oro Valley

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →